Zenas BioPharma : ZBIO

ZBIO

Stock Data

$19.36

$0.04 (0.21%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Zenas BioPharma, Inc. is a clinical-stage biopharmaceutical company based in Waltham, Massachusetts, specializing in the development and commercialization of innovative immunotherapy solutions. The company is committed to addressing significant unmet medical needs, particularly in the fields of autoimmune and rare diseases, and has established a promising pipeline of therapies powered by its proprietary technology platforms. By focusing on enhancing immune responses, Zenas aims to improve patient outcomes and strengthen its position as a leader in the biopharmaceutical industry.